COMMUNIQUÉS West-GlobeNewswire

OneMedNet Signs Mediplexus as its 11th Channel Partner, Expanding the Company’s Real World Data Footprint into Korea and the Asia Pacific Region
07/10/2026
Agreement with Mediplexus, a subsidiary of Korean CRO C&R Research, establishes a new Asia Pacific distribution channel for OneMedNet’s first-party, direct-from-source multimodal Real World Data MINNEAPOLIS, Oct. 07 [...]
Ultragenyx Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $210 Million
07/10/2026
NOVATO, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that it has entered into a definitive agreement to sell a Rare Pediatric Disease Priority Review Voucher ( [...]
Achieve Life Sciences Appoints Kaitlyn Tuson as Senior Vice President, Marketing and Communications
07/10/2026
Brings 15 years of pharma launch, health system, and direct-to-patient engagement experience as Achieve prepares for potential commercialization of cytisinicline SEATTLE and VANCOUVER, British Columbia, Oct. 07, 2026 ( [...]
SEMA4D Blockade Reshapes the Tumor Immune Environment in Neoadjuvant Melanoma Study
07/10/2026
Nature Communications publication provides new evidence that Vaccinex’s pepinemab may help reshape the tumor environment to support a coordinated immune attack on cancer, potentially complementing checkpoint inhibitors [...]
Wellspect HealthCare Announces U.S. Medicare Reimbursement Access for Surity™ Urinary Management Portfolio
07/10/2026
Traditional Medicare reimbursement supports broader access to non-invasive management options for eligible beneficiaries living with permanent urinary incontinence MÖLNDAL, Sweden, Oct. 07, 2026 (GLOBE NEWSWIRE) -- [...]
NetraMark Founder Dr. Joseph Geraci to Participate in H.C. Wainwright’s AI-Based Drug Discovery and Development Conference
07/10/2026
Panel discussion to explore competitive differentiation as AI reshapes drug discovery and development TORONTO, Oct. 07, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc . (the "Company" or "NetraMark") (TSX: AIAI) (OTCQB [...]
Tria Federal Launches Healthcare Trilemma Campaign to Open a New Conversation in Federal Health
07/10/2026
New microsite and e-book give federal leaders a shared framework for navigating tradeoffs between cost, quality, and access to care ARLINGTON, Va., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Tria Federal today launched a new [...]
Commure Appoints Nick Apeland as President of Go-to-Market
07/10/2026
Healthcare veteran Nick Apeland to lead Commure’s Go-to-Market at a time of rapid growth for the business, now serving over 500 health systems and practices Former Revenue leader who built and scaled Qualtrics [...]
Clearmind Advances Dialogue with U.S. Federal Government on Psychedelic Therapies, Submitting Recommendations to FDA
07/10/2026
Company Calls for Consideration of New Regulatory Pathways and Cost Saving of Non-Hallucinogenic Neuroplastogens for Alcohol Use Disorder Vancouver, Canada, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. ( [...]
Avaí Bio and Austrianova Hold First Joint Steering Committee Meeting with Ospedale San Raffaele for Diabetes Cell Therapy Program
07/10/2026
LAS VEGAS, NEVADA, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Avaí Bio, Inc. (OTCQB: AVAI) (“Avaí” or the “Company”) and its joint venture partner Austrianova, today announced the first joint steering committee meeting for their [...]
Moleculin Biotech to Participate in Advances in Oncology Panel at the 2026 Maxim Growth Summit
07/10/2026
HOUSTON, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. (Nasdaq: MBRX) (“Moleculin” or the “Company”) today announced that it will present at the upcoming 2026 Maxim Growth Summit in New York, NY. Details of [...]
Artelo Biosciences Selected for its First-Ever Company Presentation at BIO-Europe 2026 to Showcase Clinical Progress and Expanding Potential of its Novel FABP5 Inhibitor Platform
07/10/2026
Presentation to feature results from first clinical study of ART26.12 and highlight the potential of FABP5 inhibition across multiple indications BIO-Europe provides a key platform to advance ongoing discussions and [...]
Integrity Care Group Enters Two New States and Strengthens Core Market with Acquisition of 15 NextCare Clinics; Now Offers Access to High-Quality Healthcare in 100 Clinics Across Five States
07/10/2026
The acquisition follows the recent unification of Xpress Wellness and Integrity Urgent Care under a single masterbrand – Integrity Care Group Key facts of this press release: Integrity Care Group acquired 15 NextCare [...]
BioCardia Presents CardiAMP HF II Trial Design at Heart Failure Society of America Annual Scientific Meeting
07/10/2026
SUNNYVALE, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced [...]
Optimi Health to Present at the ThinkEquity Conference
07/10/2026
VANCOUVER, British Columbia, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Optimi Health Corp. (Nasdaq: OPTH) (CSE: OPTI) (FSE: 8BN) (“ Optimi ” or “the Company ”), a commercial-stage pharmaceutical manufacturer and clinical-stage [...]
AIM ImmunoTech’s Strategy to Address Immune Resistance in Pancreatic Cancer Featured in BioTuesdays
07/10/2026
CEO interview explores Ampligen’s potential to extend survival and improve quality of life as AIM advances toward pivotal development Access the article here OCALA, Fla., Oct. 07, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech [...]
NeOnc among Names with 2026 Breakthroughs that Offer New Hope in the Fight Against Cancer
07/10/2026
NeOnc’s encouraging brain-cancer survival findings join developments from Revolution Medicines, Moderna and Merck, Johnson & Johnson, and Genmab and AbbVie. DENVER, Oct. 07, 2026 (GLOBE NEWSWIRE) -- ( www. [...]
Vystar Announces Formation of New R3ALM Corporation and Progress Toward Live Platform Launch
07/10/2026
Company Advances R3ALM Ecosystem Toward Commercial Launch and Announces Multiple Tokenization Projects BOSTON, MA, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Vystar Corporation (OTCQB: VYST) today announced that, following the [...]
DCI Edge Introduces Series 5 Plus Dental Stools with 13° Anterior-Tilt Seat and Patent-Pending Brake
07/10/2026
New clinician's and assistant's stools, from DCI Edge, pair anti-slip Edge Upholstery with a 300 lb. capacity and a 10-year warranty. Newberg, OR, Oct. 07, 2026 (GLOBE NEWSWIRE) -- DCI Edge has released the Series 5 [...]

Pages